Virtus ETF Advisers LLC Voyager Therapeutics, Inc. Transaction History

Virtus ETF Advisers LLC

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 10, 2021	SELL	$3.94 - $5.44 $140,705 - $194,273	-35,712 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$4.61 - $9.04 $2,918 - $5,722	633 Added 1.8%	35,712 $168,000
Q4 2020 Feb 12, 2021	BUY	$7.15 - $12.28 $69,126 - $118,723	9,668 Added 38.05%	35,079 $251,000
Q3 2020 Nov 13, 2020	SELL	$10.01 - $13.75 $34,664 - $47,616	-3,463 Reduced 11.99%	25,411 $271,000
Q2 2020 Aug 05, 2020	BUY	$8.05 - $14.21 $17,436 - $30,778	2,166 Added 8.11%	28,874 $364,000
Q1 2020 May 14, 2020	SELL	$6.8 - $14.66 $26,520 - $57,174	-3,900 Reduced 12.74%	26,708 $244,000
Q4 2019 Feb 13, 2020	BUY	$12.82 - $16.85 $258,681 - $339,999	20,178 Added 193.46%	30,608 $427,000
Q3 2019 Nov 12, 2019	SELL	$16.31 - $28.29 $9,476 - $16,436	-581 Reduced 5.28%	10,430 $180,000
Q2 2019 Aug 13, 2019	SELL	$19.18 - $27.88 $280,795 - $408,163	-14,640 Reduced 57.07%	11,011 $300,000
Q1 2019 May 14, 2019	SELL	$8.0 - $19.66 $28,448 - $69,910	-3,556 Reduced 12.18%	25,651 $491,000
Q4 2018 Feb 05, 2019	BUY	$8.59 - $18.05 $63,033 - $132,450	7,338 Added 33.55%	29,207 $275,000
Q3 2018 Nov 14, 2018	SELL	$17.11 - $21.74 $267,480 - $339,861	-15,633 Reduced 41.69%	21,869 $414,000
Q2 2018 Aug 10, 2018	SELL	$16.76 - $23.92 $266,567 - $380,447	-15,905 Reduced 29.78%	37,502 $733,000
Q1 2018 May 14, 2018	BUY	$16.16 - $31.31 $481,907 - $933,695	29,821 Added 126.44%	53,407 $1 Million
Q4 2017 Feb 14, 2018	BUY	$12.26 - $25.88 $289,164 - $610,405	23,586	23,586 $392,000

130

34.7M

39.7K

34.6K

Ticker VYGR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,647,600
Market Cap $207M
Description
Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

Stay updated on Virtus ETF Advisers LLC with notifications on news.